Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $2.5 Million - $3.17 Million
-10,896 Reduced 19.3%
45,547 $12 Million
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $35,464 - $39,997
-158 Reduced 0.28%
56,443 $12.7 Million
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $64,598 - $71,887
-280 Reduced 0.49%
56,601 $13.8 Million
Q1 2022

Apr 14, 2022

BUY
$219.27 - $242.57 $120,379 - $133,170
549 Added 0.97%
56,881 $13.8 Million
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $888,396 - $1.02 Million
4,467 Added 8.61%
56,332 $12.7 Million
Q3 2021

Oct 21, 2021

BUY
$212.27 - $248.7 $461,474 - $540,673
2,174 Added 4.38%
51,865 $11 Million
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $140,615 - $156,002
602 Added 1.23%
49,691 $12.1 Million
Q1 2021

Apr 20, 2021

SELL
$221.91 - $258.6 $595,828 - $694,341
-2,685 Reduced 5.19%
49,089 $12.2 Million
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $821,594 - $978,372
3,797 Added 7.91%
51,774 $11.9 Million
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $126,241 - $140,391
538 Added 1.13%
47,977 $12.2 Million
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $44,902 - $55,101
227 Added 0.48%
47,439 $11.2 Million
Q1 2020

Apr 23, 2020

SELL
$182.24 - $241.7 $6,378 - $8,459
-35 Reduced 0.07%
47,212 $9.57 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $2.06 Million - $2.64 Million
10,868 Added 29.87%
47,247 $11.4 Million
Q3 2019

Oct 31, 2019

BUY
$174.11 - $208.62 $137,546 - $164,809
790 Added 2.22%
36,379 $7.04 Million
Q2 2019

Aug 06, 2019

BUY
$166.7 - $195.41 $90,351 - $105,912
542 Added 1.55%
35,589 $6.56 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $3.38 Million - $3.81 Million
18,694 Added 114.32%
35,047 $6.66 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $2.92 Million - $3.41 Million
16,353 New
16,353 $3.18 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cabot Wealth Management Inc Portfolio

Follow Cabot Wealth Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cabot Wealth Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cabot Wealth Management Inc with notifications on news.